$0.99
+0.00 (+0.00%)
Open$0.99
Previous Close$0.99
Day High$1.02
Day Low$0.97
52W High$3.09
52W Low$1.20
Volume—
Avg Volume115.1K
Market Cap185.60M
P/E Ratio—
EPS$-0.19
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+3,907.1% upside
Current
$0.99
$0.99
Target
$39.67
$39.67
$29.46
$39.67 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 401.11M | 331.11M | 81.33M |
| Net Income | -38,312,932 | -28,464,288 | 15.27M |
| Profit Margin | -9.6% | -9.1% | 18.8% |
| EBITDA | -21,952,381 | -17,215,421 | 21.57M |
| Free Cash Flow | — | — | 16.42M |
| Rev Growth | +21.1% | +21.1% | -3.5% |
| Debt/Equity | 0.22 | 0.22 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |